| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6104479 | Journal of Hepatology | 2013 | 4 Pages |
Abstract
Ibandronate is a widely used bisphosphonate with no previously well documented hepatotoxicity. We report the first case of ibandronate-related hepatotoxicity and, to our knowledge, the first case of immune-mediated drug-induced liver injury (DILI) related to bisphosphonates.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Nicolas Goossens, Laurent Spahr, Laura Rubbia-Brandt,